XenoPort’s CEO Presents at Citi 2013 Global Healthcare Conference (Transcript) – Seeking Alpha

by admin on February 27, 2013

XenoPort's CEO Presents at Citi 2013 Global Healthcare Conference (Transcript)
Seeking Alpha
In Japan, trade name is Regnite where it is approved for the treatment of restless legs syndrome and we have a partnership with Astellas for commercialization of Regnite in Japan and five other Asian countries. In addition to that commercial product

and more »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: